PRISMA-P (preferred reporting items for systematic review and meta-analysis protocols) 2015 checklist: recommended items to addressin a systematic review protocol | ||
Section and topic | interviewer Item No | Checklistitem |
Administrative information | ||
Title: | ||
Identification | 1a | Identify the report as a protocol of a systematic review |
Update | 1b | If the protocol is for an update of a previous systematic review, identify as such |
Registration | 2 | If registered, provide the name of the registry (such as PROSPERO) and registration number |
Authors: | ||
Contact | 3a | Provide name, institutional affiliation, e-mail address of all protocol authors; provide physical mailing address of corresponding author |
Contributions | 3b | Describe contributions of protocol authors and identify the guarantor of the review |
Amendments | 4 | If the protocol reprents an amendment of a previously completed or published protocol, identify as such and list changes;otherwi, state plan for documenting important protocol amendments |
Support: | ||
Sources | 5a | Indicate sources of financial or other support for the review |
Sponsor | 5b | Provide name for the review funder and/or sponsor |
Role of sponsor or funder | 5c | Describe roles of funder(s), sponsor(s), and/or institution(s), if any, in developing the protocol |
Introduction | ||
Rationale | 6 | Describe the rationale for the review in the context of what is already known.a |
Objectives | 7 | Provide an explicit statement of the question(s) the review will address with reference to participants, interventions, comparators, and outcomes (PICO) |
Methods | ||
Eligibility criteria | 8 | Specify the study characteristics (such as PICO, study design, tting, time frame) and report characteristics (such as years considered, language, publication status) to be ud as criteria for eligibility for the review |
动感英语笔记 |
Information sources | 9 | Describe all intended information sources (such as electronic databas, contact with study authors, trial registers or other grey literature sources) with planned dates of coverage |
Search strategy | 10 | Prent draft of arch strategy to be ud for at least one electronic databa, including planned limits, such that it could be repeated |
Study records: | ||
Data management | 11a | Describe the mechanism(s) that will be ud to manage records and data throughout the review | 我也爱你英文
Selection process | 11b | State the process that will be ud for lecting studies (such as two independent reviewers) through each pha of the review (that is, screening, eligibility and inclusion in meta-analysis) |
Data collection process | 11c | Describe planned method of extracting data from reports (such as piloting forms, done independently, in duplicate), any process for obtaining and confirming data from investigators |
Data items | 12 | List and define all variables for which data wil lbe sought (such as PICOitems, funding sources), any pre-planned data assumptions and simplifications |
Outcomes and prioritization | 心照不宣的反义词 13 | List and define all outcomes for which data will be sought, including prioritization of main and additional outcomes, with rationale |
Risk of bias in individual studies | 14 | Describe anticipated methods for asssing risk of bias of individual studies, including whether this will be done at the outcome or study level, or both; state how this information will be ud in data synthesis |
Data synthesis | 15a | Describe criteria under which study data will be quantitatively synthesid |
15b | If data are appropriatefor quantitative synthesis, describe planned summary measures, methods of handling data and methods of combining data from studies, including any planned exploration of consistency (such as I2, Kendall’s τ) | |
15c contacts | Describe any propod additional analys (such as nsitivity or subgroup analys, meta-regression) | |
15d | If quantitative synthesisis not appropriate, describe the type of summary planned | |
Meta-bias(es) | 16 | Specify any planned asssment of meta bias(es) (such as publication bias across studies, lective reporting within studies) |
Confidence in cumulative evidence | 17 | Describe how the strength of the body of evidence will be assd (such as GRADE) |
坎土曼 |
PRISMA-P 2015清单: 系统综述和荟萃分析计划书优先报告——适用于系统评价计划书的推荐条目 | ||
章节和主题 | 条目编号 | 清单条目 |
管理信息 | ||
标题 | ||
识别 | 1a | 从标题可以识别报告是系统评价的计划书 |
更新 | 1b | 从标题可以识别计划书是对之前发表的的系统评价进行更新 |
注册 | 2 | 如果已经注册,请提供注册处和注册号 |
作者 | ||
联系 | 3a | 提供参与计划书的所有作者姓名,所属机构单位,以及邮箱;提供通讯作者的详细通讯地址 |
贡献 | 3b | 描述计划书中各个作者的贡献,并且明确担保人 |
修正 | 4 | 如果该计划书是对之前已完成或已发表的计划书的修正,请确认并列出修改清单;否则,阐述记录计划书重大修正的计划 |
支持 | ||
来源 | lay it down slow5a | 标明资金来源或其它支持 |
赞助 | 5b | 提供资助者姓名或者赞助商名称 |
资助者或赞助商的角色 | 5c | 如果资助者,赞助商和/或机构参与计划书其中,请描述他们的角色 climate change |
介绍 | ||
论据 | 6 | 在已知的背景下陈述该系统评价的立题依据 |
目标 | 7 | 根据人群、干预、对照和结局(PICO)对系统评价的研究问题进行明确清晰的阐述 |
方法 | ||
纳入标准 | 8 | 明确系统评价纳入研究的特点(比如PICO、研究设计、试验场所、时间点)以及其他研究报告特点(比如发表年代、语种、发表状态) |
羊脂球读书笔记 |
本文发布于:2023-06-27 16:58:12,感谢您对本站的认可!
本文链接:https://www.wtabcd.cn/fanwen/fan/90/159580.html
版权声明:本站内容均来自互联网,仅供演示用,请勿用于商业和其他非法用途。如果侵犯了您的权益请与我们联系,我们将在24小时内删除。
留言与评论(共有 0 条评论) |